Midtrimester bacterial vaginosis and cervical length in women at risk for preterm birth.

M. Mancuso,D. Figueroa,J. Szychowski,M. Paden,J. Owen

DOI: https://doi.org/10.1016/j.ajog.2010.11.003

IF: 9.8

2011-04-01

American Journal of Obstetrics and Gynecology

Abstract:

What problem does this paper attempt to address?

Endovascular treatment for acute basilar artery occlusion due to different stroke etiologies of large artery atherosclerosis and cardioembolism.

Huihui Liu,Guoyong Zeng,Hongliang Zeng,Yang Yu,Feixue Yue,Yingbing Ke,Zhizhong Yan,Jie Pu,Jun Zhang,Wan Wei,Dengke He,Yupeng Wu,Xianjun Huang,Peiyang Zhou

DOI: https://doi.org/10.1177/23969873221101285

IF: 6.1

2022-01-01

European Stroke Journal

Abstract:Introduction:Stroke etiology may affect the prognosis of acute basilar artery occlusion (BAO). This study aimed to estimate the efficacy and safety of endovascular treatment (EVT) in BAO strokes due to the underlying stroke etiologies of large artery atherosclerosis (LAA) and cardioembolism (CE). Patients and methods:Patients with LAA and CE subtypes from the registry EVT for Acute Basilar Artery Occlusion Study (BASILAR) were selected for this analysis. We estimated the EVT treatment effect relative to standard medical treatment (SMT) in these patients by using a propensity score approach with inverse probability of treatment weighted estimation. Outcomes included 90-day favorable functional outcomes (modified Rankin scale (mRS) 0-3), functional independence (mRS 0-2), all-cause mortality, and symptomatic intracranial hemorrhage (sICH). Results:A total of 744 patients were included in the final analysis. After weighting with inverse probability of treatment estimation, the patients who, based on their characteristics, were treated with EVT rather than SMT, demonstrated higher rates of favorable functional outcomes in both the LAA (29.2% vs 11.7%, adjusted OR with 95% CI: 4.34 [2.15-8.78], p < 0.001) and the CE subtype (36.0% vs 8.1%, adjusted OR with 95% CI: 9.14 [1.96-42.55], p = 0.005). A similar finding was also observed for functional independence. EVT patients also demonstrated lower rates of mortality than SMT. Among EVT patients, no significant difference was observed in mortality or sICH between LAA and CE groups, but LAA patients had lower rates of favorable functional outcome and functional independence (29.2% vs 37% and 24.2% vs 32.9%, respectively), where the latter remained significant after adjustment for imbalances in baseline data (p = 0.04). Conclusions:In acute BAO strokes, both LAA and CE patients who, based on their characteristics, were treated with EVT rather than SMT, demonstrated better outcomes. Among EVT patients, LAA and CE subtypes displayed important baseline and treatment differences, and LAA patients were less likely to achieve functional independence at 3 months, but mortality and sICH were similar between LAA or CE subtypes. These results need to be confirmed in future clinical trials.
Endovascular Treatment for Minor Acute Ischemic Strokes with Large Vessel Occlusion

Rui Xue,Wansi Zhong,Ying Zhou,Yaode He,Shenqiang Yan,Zhicai Chen,Jianan Wang,Xiaoxian Gong,Min Lou

DOI: https://doi.org/10.1161/jaha.122.027326

2022-01-01

Abstract:Background It remains uncertain whether patients with minor acute ischemic stroke with large vessel occlusion benefit from endovascular treatment (EVT). We aim to evaluate the outcomes of EVT in minor acute ischemic stroke with anterior circulation large vessel occlusion. Methods and Results Based on a nationwide prospective stroke registry, patients with minor acute ischemic stroke with anterior circulation large vessel occlusion within 24 hours of onset were divided into groups receiving standard medical treatment plus EVT or standard medical treatment alone. Primary outcome was excellent functional outcome defined as modified Rankin Scale score 0 to 1 at 90 days. In addition, a multivariable logistic regression model was used to analyze the effect of EVT guided by perfusion imaging. A total of 572 patients with median age 68 years (interquartile range=60–77) and median National Institutes of Health Stroke score 3 (interquartile range =2–4) were identified and 123 patients were treated with standard medical treatment plus EVT. EVT was not associated with excellent functional outcome (unadjusted odds ratio [OR], 0.771 [95% CI, 0.516–1.151]; adjusted OR, 0.793 [95% CI, 0.515–1.219]; P=0.290). However, therapy selection guided by perfusion imaging was a modifier of EVT effect on outcomes, as EVT was significantly associated with excellent functional outcome (60.0% versus 50.8%, unadjusted OR, 1.451 [95% CI, 0.643–3.272]; adjusted OR, 2.849 [95% CI, 1.006–8.067]; P=0.049) but not with symptomatic intracerebral hemorrhage in the imaging‐guided group. Conclusions Although functional outcomes in minor acute ischemic stroke caused by anterior circulation large vessel occlusion were not improved from the routine use of EVT, our results suggested that EVT guided by perfusion imaging could be beneficial for those patients. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT 04487340.
Endovascular Treatment or General Treatment: How Should Acute Ischemic Stroke Patients Choose to Benefit from Them the Most?

Weinan Yang,Lincheng Zhang,Qigu Yao,Weiyan Chen,Weiji Yang,Suqing Zhang,Lan He,Hong Li,Yuyan Zhang

DOI: https://doi.org/10.1097/md.0000000000020187

IF: 1.6

2020-01-01

Medicine

Abstract:Background: Acute ischemic stroke due to large-vessel occlusion is a leading cause of death and disability, and therapeutic time window was limited to 4.5 hour when treated with intravenous thrombolysis. It has been acknowledged that endovascular treatment (EVT) is superior to general treatment (only medication, including intravenous recombinant tissue plasminogen activator (rt-PA)) in improving the outcome of AIS since 2015. However, the benefits were limited to improvement of functional outcomes and functional independence. Hence, this meta-analysis was conducted to summarize the benefits of EVT for acute ischemic stroke, explore underlying indications of EVT for AIS patients and suggest implications for clinical practice and future research. Methods: A search was performed to identify eligible studies in PubMed, Scopus and Web of Science updated to February 5, 2019. Functional outcomes, the modified Rankin Scale (mRS) 0–1, mRS 0–2, all-cause mortality, symptomatic intracerebral hemorrhage and asymptomatic intracerebral hemorrhage (aICH) at 90 days were selected as outcomes. Data was pooled to calculate the odds ratio (OR) and 95% confidence interval (CI). Heterogeneity, subgroup analysis, sensitivity analysis and publication bias were also performed in this meta-analysis. Results: Eighteen studies comprising 3831 patients were included and analyzed in this meta-analysis. In comparison with general treatment, improved functional outcomes (mRS 0–1: OR = 1.68, 95% CI = 1.43–1.97, inconsistency index [I2] = 57%, P < .00001; mRS 0–2: OR = 1.78, 95% CI = 1.55–2.03, I2 = 69%, P < .00001), reduced risk of all-cause mortality (OR = 0.82, 95% CI = 0.70–0.98, I2 = 27%, P = .03) but higher risk of aICH (OR = 1.43, 95% CI = 1.05–1.95, I2 = 0%, P = .02) at 90 days were found in AIS patients treated with EVT. Age < 70, National Institutes of Health Stroke Scale ≥20 and maximum delay for invention>5 hours could improve clinical outcomes following EVT. In sensitivity analysis, it showed that 2 studies had a great influence on the pooled ORs. No potential publication bias was found in this meta-analysis. Conclusion: Taken together, EVT, which led to improved functional outcomes and decreased risk of death, is superior to general treatment for AIS patients with age < 70, National Institutes of Health Stroke Scale ≥20 and maximum delay for invention>5 hours. Moreover, it suggests that “with mechanical thrombectomy” is potential favorable factor for improving aICH in comparison with general treatment.
Endovascular therapy versus medical management for ischemic stroke presenting beyond 24 hours: Systematic review and meta-analysis

Derrek Schartz,Rohin Singh,Nathaniel Ellens,Sajal Medha K Akkipeddi,Clifton Houk,Tarun Bhalla,Thomas Mattingly,Matthew T Bender

DOI: https://doi.org/10.1016/j.clineuro.2024.108415

Abstract:Objective: The ideal management for ischemic stroke presenting in the very late time window, or beyond 24 hours from onset, is poorly understood. It is unknown if endovascular therapy (EVT) or best medical management (MM) is associated with superior clinical outcomes. Methods: A systematic literature and comparative meta-analysis was completed to evaluate the safety and efficacy of EVT vs. MM for stroke presenting beyond 24 hours. Outcome measures included: 90 day functional independence (mRS 0-2), 90 day mortality, and symptomatic intracranial hemorrhage (sICH) occurrence. A random effects model was used for quantitative synthesis. Results: From the five included studies, a total of 704 patients were included with 461 treated with EVT and 243 treated with MM alone. The proportion of patients achieving functional independence was significantly higher in patients treated with EVT (34.6 %) compared to MM alone (15.9 %) (OR: 4.24; CI: 2.61-6.88, P < 0.00001; I2 =0 %). While sICH occurred more in EVT patients (6.8 %) compared to MM (2.8 %), this was not significant (OR: 1.96; CI: 0.61-6.27, P=0.26; I2 = 67 %). Lastly, 90 day morality occurred significantly less in the EVT group (24.5 %) compared to patients treated with MM (33.1 %), and with significantly lower odds (OR: 0.51; CI: 0.35-0.73, P=0.0003; I2=0 %). Conclusions: In certain patients presenting beyond 24 hours with ischemic stroke, EVT is associated with a significantly higher odds of achieving functional independence and lower odds of mortality compared with MM. While these results do not function as proof, they do encourage further research into extending the window beyond 24 hours for EVT. Randomized clinical trials are warranted to validate these findings.
Safety and efficacy of endovascular treatment for acute ischemic stroke of large-vessel occlusion beyond the time window based on imaging evaluation

Shi-Dun Chen,Cheng-Bao Yang,Yong-Xiang Wang,Yue-Han Yin,Bu-Lang Gao,Chun-Guang Chen

DOI: https://doi.org/10.1177/15910199241250081

IF: 1.7

2024-04-28

Interventional Neuroradiology

Abstract:Interventional Neuroradiology, Ahead of Print. PurposeEndovascular treatment (EVT) of acute ischemic stroke caused by large-vessel occlusion (AIS-LVO) over 24 h of onset remains controversial. This study was to explore the safety and efficacy of EVT for patients with AIS-LVO between 24 and 72 h of symptom onset after rigorous imaging evaluation.MethodsPatients with AIS-LVO treated with EVT were retrospectively enrolled and divided into two groups according to the time from symptom onset to groin puncture: 64 in the over-time group (>24 h) and 257 in the within-time group (≤24 h). Outcomes included 3-month modified Rankin Scale (mRS) score, functional independence (defined as mRS 0–2), successful cerebral reperfusion, symptomatic intracranial hemorrhage (sICH), and 3-month mortality.ResultsPatients in the over-time group had no significant differences in the functional independence (40.6% vs 42.5%, odds ratio or OR 0.91, 95% confidence interval or CI 0.52–1.60, p = 0.753), successful reperfusion (96.7% vs 95.8%, OR 0.76, 95% CI 0.36–1.59, p = 0.467), sICH (8.3% vs 6.7%, OR 1.20, 95% CI 0.42–3.38, p = 0.735), 3-month mortality (13.3% vs 10.8%, OR 1.17, 95% CI 0.51–2.70, p = 0.716) compared with patients in the within-time group. After matching adjustment, the results did not change significantly.ConclusionsThe safety and effectiveness of EVT treatment for selected AIS-LVO patients with symptom onset of 24–72 h are not inferior to those treated within 6–24 h of onset, especially in a short term based on the pre-treatment advanced neuroimaging computed tomography perfusion even though further investigations are necessary to prove this finding.

radiology, nuclear medicine & medical imaging,clinical neurology
Endovascular therapy beyond 24 hours for anterior circulation large vessel occlusion or stenosis in acute ischemic stroke: a retrospective study

An Wen,Wen-feng Cao,Chao Zhao,Ling-feng Wu,Yong-liang Zhou,Zheng-bing Xiang,Wei Rao,Shi-min Liu

DOI: https://doi.org/10.3389/fneur.2023.1237661

IF: 3.4

2023-12-07

Frontiers in Neurology

Abstract:Background: To assess the clinical and safety outcomes of endovascular treatment (EVT) administered more than 24 h after the onset of symptoms in patients with acute ischemic stroke resulting from anterior circulation large-vessel occlusion or stenosis (AIS-ACLVO/S). Methods: We enrolled consecutive AIS-ACLVO/S patients who received EVT in our hospital between January 2019 and February 2022 and divided them into two groups based on the time from AIS onset to EVT: EVT 24 h group. The successful reperfusion (modified thrombolysis in cerebral infarction, [mTICI] ≥2b), 90-day modified Rankin Scale score (mRS), intracranial hemorrhage (ICH), and symptomatic ICH (sICH), as well as mortality, were analyzed in the two groups of patients. Results: A total of 239 patients were included in the study, with 214 patients in the EVT 24 h group (62.80 ± 2.0 years, 22 males). Both groups were similar in terms of hypertension, diabetes history, responsible vessels, and Alberta stroke program early computed tomography scores ( p > 0.05). However, the EVT 24 h group. AIS etiology differed between the groups, with more cases of large artery atherosclerosis in the EVT > 24-h group and more cases of cardioembolism in the EVT 24-h than in the EVT < 24-h group (80% vs. 39.7%, p 24-h group (0% vs. 24.8%, p < 0.001). Conclusion: In our study, we found that EVT beyond 24 h of symptom onset in patients selected with multimodal MR screening, was associated with high functional independence rates and low mortality. Larger or randomized studies are needed to confirm these findings.

neurosciences,clinical neurology
Safety and clinical outcomes of endovascular therapy versus medical management in late presentation of large ischemic stroke

Adnan Mujanovic,Daniel Strbian,Jelle Demeestere,João Pedro Marto,Volker Puetz,Raul G Nogueira,Mohamad Abdalkader,Simon Nagel,Jean Raymond,Marc Ribo,Patrik Michel,Shinichi Yoshimura,Osama O Zaidat,Simon Winzer,Santiago Ortega-Gutierrez,Sunil A Sheth,James E Siegler,Anne Dusart,Diogo C Haussen,Hilde Henon,Bettina L Serrallach,Mahmoud H Mohammaden,Markus A Möhlenbruch,Marta Olive-Gadea,Ajit S Puri,Nobuyuki Sakai,Piers Klein,Liisa Tomppo,Francois Caparros,João Nuno Ramos,Mouhammad Jumaa,Syed Zaidi,Tomas Dobrocky,Nicolas Martinez-Majander,Stefania Nannoni,Flavio Bellante,Aaron Rodriguez-Calienes,Sergio Salazar-Marioni,Pekka Virtanen,Daniel Po Kaiser,Rita Ventura,Jessica Jesser,Alicia C Castonguay,Muhammad M Qureshi,Hesham E Masoud,Milagros Galecio-Castillo,Manuel Requena,Riikka Lauha,Wei Hu,Eugene Lin,Zhongrong Miao,Daniel Roy,Hiroshi Yamagami,David J Seiffge,Davide Strambo,Peter A Ringleb,Robin Lemmens,Urs Fischer,Thanh N Nguyen,Johannes Kaesmacher

DOI: https://doi.org/10.1177/23969873241249406

Abstract:Introduction: The benefit of endovascular therapy (EVT) among stroke patients with large ischemic core (ASPECTS 0-5) in the extended time window outside of trial settings remains unclear. We analyzed the effect of EVT among these stroke patients in real-world settings. Patients and methods: The CT for Late Endovascular Reperfusion (CLEAR) study recruited patients from 66 centers in 10 countries between 01/2014 and 05/2022. The extended time-window was defined as 6-24 h from last-seen-well to treatment. The primary outcome was shift of the 3-month modified Rankin scale (mRS) score. Safety outcomes included symptomatic intracranial hemorrhage (sICH) and mortality. Outcomes were analyzed with ordinal and logistic regressions. Results: Among 5098 screened patients, 2451 were included in the analysis (median age 73, 55% women). Of patients with ASPECTS 0-5 (n = 310), receiving EVT (n = 209/310) was associated with lower 3-month mRS when compared to medical management (median 4 IQR 3-6 vs 6 IQR 4-6; aOR 0.4, 95% CI 0.2-0.7). Patients undergoing EVT had higher sICH (11.2% vs 4.0%; aOR 4.1, 95% CI 1.2-18.8) and lower mortality (31.6% vs 58.4%, aOR 0.4; 95% CI 0.2-0.9) compared to medically managed patients. The relative benefit of EVT was comparable between patients with ASPECTS 0 and 5 and 6-10 in the extended time window (interaction aOR 0.9; 95% CI 0.5-1.7). Conclusion: In the extended time window, patients with ASPECTS 0-5 may have preserved relative treatment benefit of EVT compared to patients with ASPECTS 6-10. These findings are in line with recent trials showing benefit of EVT among real-world patients with large ischemic core in the extended time window. Trial registration number: clinicaltrials.gov; Unique identifier: NCT04096248.
Endovascular treatment versus standard medical treatment in patients with established large infarct: a cohort study

Changwei Guo,Linyu Li,Jiandi Huang,Jie Yang,Jiaxing Song,Jiacheng Huang,Zhouzhou Peng,Nizhen Yu,Chang Liu,Weilin Kong,Jinrong Hu,Li Chen,Meng Guo,Chengsong Yue,Dahong Yang,Xiang Liu,Jian Miao,Mengmeng Wang,Xiangyun Luo,Zhaoyin Tang,Xiubing Bai,Duolao Wang,Fengli Li,Qingwu Yang,Wenjie Zi

DOI: https://doi.org/10.1097/JS9.0000000000001539

2024-08-01

Abstract:Background: Previous trials confirmed the benefit of endovascular treatment (EVT) in acute large core stroke, but the effect of EVT on outcomes in these patients based on noncontrast computed tomography (NCCT) in real-world clinical practice was unclear. The aim of this study was to explore the effect of EVT versus standard medical treatment (SMT) in patients with large ischemic core stroke defined as Alberta Stroke Program Early CT Score (ASPECTS) ≤5 based on NCCT alone. Materials and methods: Patients with acute large core stroke at 38 Chinese centers between November 2021 and February 2023 were reviewed from a prospectively maintained database. The primary outcome was favorable functional outcome [modified Rankin Scale score (mRS), 0-3] at 90 days. Safety outcomes included 48 h symptomatic intracerebral hemorrhage (sICH) and 90-day mortality. Results: Of 745 eligible patients recruited at 38 stroke centers between November 2021 and February 2023, 490 were treated with EVT+SMT and 255 with SMT alone. One hundred and eighty-one (36.9%) in the EVT group achieved favorable functional independence versus 48 (18.8%) treated with SMT only [adjusted risk ratio (RR), 1.86; 95% CI: 1.43-2.42, P <0.001; adjusted risk difference (RD), 13.77; 95% CI: 7.40-20.15, P <0.001]. The proportion of sICH was significantly higher in patients undergoing EVT (13.3 vs. 2.4%; adjusted RR, 5.17; 95% CI: 2.17-12.32, P <0.001; adjusted RD, 10.10; 95% CI: 6.12-14.09, P <0.001). No significant difference of mortality between the groups was observed (41.8 vs. 49.0%; adjusted RR, 0.91; 95% CI: 0.77-1.07, P =0.24; adjusted RD, -5.91; 95% CI: -12.91-1.09, P =0.1). Conclusion: Among patients with acute large core stroke based on NCCT in real-world, EVT is associated with better functional outcomes at 90 days despite of higher risk of sICH. Rates of procedure-related complications were relatively higher in the EVT+SMT group.
Association between time to treatment and clinical outcomes in endovascular thrombectomy beyond 6 hours without advanced imaging selection

Permesh Singh Dhillon,Waleed Butt,Anna Podlasek,Norman McConachie,Robert Lenthall,Sujit Nair,Luqman Malik,Pervinder Bhogal,Hegoda Levansri Dilrukshan Makalanda,Oliver Spooner,Kailash Krishnan,Nikola Sprigg,Alex Mortimer,Thomas Calvert Booth,Kyriakos Lobotesis,Philip White,Martin A James,Philip Bath,Robert A Dineen,Timothy J England

DOI: https://doi.org/10.1136/neurintsurg-2021-018564

Abstract:Background: The effectiveness and safety of endovascular thrombectomy (EVT) in the late window (6-24 hours) for acute ischemic stroke (AIS) patients selected without advanced imaging is undetermined. We aimed to assess clinical outcomes and the relationship with time-to-EVT treatment beyond 6 hours of stroke onset without advanced neuroimaging. Methods: Patients who underwent EVT selected with non-contrast CT/CT angiography (without CT perfusion or MR imaging), between October 2015 and March 2020, were included from a national stroke registry. Functional and safety outcomes were assessed in both early (<6 hours) and late windows with time analyzed as a continuous variable. Results: Among 3278 patients, 2610 (79.6%) and 668 (20.4%) patients were included in the early and late windows, respectively. In the late window, for every hour delay, there was no significant association with shift towards poorer functional outcome (modified Rankin Scale (mRS)) at discharge (adjusted common OR 0.98, 95% CI 0.94 to 1.01, p=0.27) or change in predicted functional independence (mRS ≤2) (24.5% to 23.3% from 6 to 24 hours; aOR 0.99, 95% CI0.94 to 1.04, p=0.85). In contrast, predicted functional independence was time sensitive in the early window: 5.2% reduction per-hour delay (49.4% to 23.5% from 1 to 6 hours, p=0.0001). There were similar rates of symptomatic intracranial hemorrhage (sICH) (3.4% vs 4.6%, p=0.54) and in-hospital mortality (12.9% vs 14.6%, p=0.33) in the early and late windows, respectively, without a significant association with time. Conclusion: In this real-world study, there was minimal change in functional disability, sICH and in-hospital mortality within and across the late window. While confirmatory randomized trials are needed, these findings suggest that EVT remains feasible and safe when performed in AIS patients selected without advanced neuroimaging between 6-24 hours from stroke onset.
Effect of the Time from Onset to Recanalization on the Outcomes after Endovascular Treatment in Patients with Acute Stroke Due to Posterior Circulation Large Vessel Occlusion

Wang Wei,Shi Hongchao,Zhou Feng,Hou Jiankang,Zhou Junshan,Chen Nihong

DOI: https://doi.org/10.3760/cma.j.issn.1673-4165.2019.11.001

2019-01-01

Abstract:Objective To investigate the effect of the time from onset to recanalization on the outcomes after endovascular treatment (EVT) in patients with acute stroke due to posterior circulation large vessel occlusion. Methods From May 2015 to May 2019, patients with acute ischemic stroke due to posterior circulation large vessel occlusion receiving EVT in the Department of Neurology, Nanjing First Hospital, Nanjing Medical University were enrolled retrospectively. According to the modified Rankin Scale (mRS) score at 90 d after procedure, they were divided into good outcome group (≤2) and poor outcome group (>2). Demographic and clinical data were compared between the two groups. Multivariate logistic regression analysis was used to determine the independent correlation between the time from onset to recanalization and the outcomes. Results A total of 64 patients with acute ischemic stroke due to posterior circulation large vessel occlusion treated by EVT were enrolled in this study. There were 50 males (78.0%) and 14 females (22.0%). The age was 67.52±10.30 years. The National Institutes of Health Stroke Scale (NIHSS) score was 22.04±4.17, and the time from onset to recanalization was 370.53±78.59 min. Thirty-one patients (48.0%) were in the good outcome group and 33 (52.0%) were in the poor outcome group. There were significant differences in baseline NIHSS score, systolic blood pressure, time from onset to revascularization, and the proportions of patients with tandem lesion and symptomatic intracranial hemorrhage between the two groups (all P<0.05). Multivariate logistic regression analysis showed that the longer time from onset to recanalization (odds ratio [OR] 1.317, 95% confidence interval [CI] 1.001-3.034; P=0.041) and symptomatic intracranial hemorrhage (OR 4.207, 95% CI 1.931-10.761; P=0.004) were the independent predictors of poor outcomes, while the lower baseline NIHSS score (OR 0.302, 95% CI 0.056-0.743; P=0.047) was the independent protective factor of poor outcomes. Conclusions The longer time from onset to recanalization is an independent risk factor for poor outcomes after EVT in patients with acute ischemic stroke caused by posterior circulation large vessel occlusion. Key words: Stroke; Brain ischemia; Thrombectomy; Endovascular procedures; Treatment outcome; Time factor
Clinical Outcomes of Endovascular Treatment within 24 Hours in Patients with Mild Ischemic Stroke and Perfusion Imaging Selection.

X Shang,M Lin,S Zhang,S Li,Y Guo,W Wang,M Zhang,Y Wan,Z Zhou,W Zi,X Liu

DOI: https://doi.org/10.3174/ajnr.A5644

IF: 4.9661

2018-01-01

American Journal of Neuroradiology

Abstract:BACKGROUND AND PURPOSE: Endovascular thrombectomy has been accepted as the standard of care for patients with acute ischemic stroke. Our aim was to investigate the clinical outcomes of patients with mild ischemic stroke with acute proximal large-vessel occlusion after endovascular treatment within 24 hours of symptom onset. MATERIALS AND METHODS: Between January 2014 and August 2017, ninety-three Chinese patients with mild ischemic stroke (NIHSS scores, 0-8) and large-vessel occlusion with endovascular treatment were retrospectively enrolled from 7 comprehensive stroke centers. They were divided into 2 groups: 6 hours and 6-24 hours from symptom onset to groin puncture. We analyzed their modified Rankin Scale scores at 90 days, symptomatic intracranial hemorrhage at 48 hours, and mortality during 90 days. Multivariable linear regression analysis was used to identify predictors for NIHSS shift after discharge. RESULTS: Twenty-nine patients received endovascular treatment within 6-24 hours after symptom onset and had an imaging mismatch based on perfusion CT or diffusion-weighted MR imaging. There were no substantial differences between the 2 groups in 90-day functional independence (P = .54) and the risks of the combination of symptomatic intracranial hemorrhage and death (P = .72). Two significant indicators of NIHSS shift were 48-hour symptomatic intracranial hemorrhage (unstandardized = 7.28; 95% CI, 3.48-11.1; P < .001) and baseline systolic blood pressure (unstandardized = 0.08; 95% CI, 0.03-0.14; P = .005). CONCLUSIONS: Patients with mild ischemic stroke and large-vessel occlusion in the anterior circulation, an imaging mismatch, and endovascular treatment within 6-24 hours of initial symptoms showed no heterogeneity in the efficacy and safety outcome compared with those treated 6 hours from symptom onset.
A comparison of endovascular therapy and medical management in patients with large vessel occlusion mild stroke treated between 2015 and 2023: a systematic review and meta-analysis

Yiqiao Xu,Xin Liu,Hao Li

DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.107721

IF: 2.677

2024-04-15

Journal of Stroke and Cerebrovascular Diseases

Abstract:Objective Endovascular therapy (EVT) is recommended for patients with acute large-vessel occlusion (LVO) However, its efficacy and safety compared to medical management (MM) in patients with a National Institutes of Health Stroke Scale (NIHSS) score of ≤6 remains unclear. This meta-analysis compared EVT with medical MM in patients with large vessel occlusion mild stroke treated between 2015 and 2023, following the publication of the first randomized controlled trial. Materials and methods Biomedical database searches (inception to March 21, 2023) retrieved articles reporting favorable functional outcome(modified Rankin Scale [mRS] 0-1) and functional independence (mRS 0-2), 90-day mortality and symptomatic intracranial hemorrhage (sICH). We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (PRISMA) to maintain methodological rigor and transparency in our meta-analysis. Results We conducted a meta-analysis of 22 studies (4,985 patients) to reveal no significant differences in favorable functional outcomes and independence across all groups. However, in patients treated between 2015 and 2023, EVT exhibited a higher risk of 90-day mortality (Odds Ratio [OR] = 1.84, 95% Confidence Interval [CI] [1.10, 3.07], p = 0.02) and sICH (OR = 3.36, 95% CI [1.96, 6.66], p < 0.01). EVT correlated with elevated sICH in the anterior circulation (OR=2.94, 95%CI [1.82, 4.74], p<0.01) regardless of the proximal (OR=2.20, 95%CI [1.04, 4.69], p=0.04) or distal (OR=3.44, 95%CI [1.43, 8.32], p<0.01) location of the occlusion. EVT correlated with elevated sICH rates in patients treated within 6 hours of symptom onset or those with NHISS≤5. Conclusion In patients treated between 2015 and 2023, EVT and MM did not differ in efficacy in acute LVO mild stroke; MM associated with better safety outcomes. Rigorous randomized controlled trials are warranted.

neurosciences,peripheral vascular disease
Abstract 152: Endovascular Therapy versus Medical Management for Acute Ischemic Stroke With Large Infarct: A Time-Benefit Relationship Analysis

Guangxiong Yuan,Hongfei Sang,Thanh Nguyen,Xiaochuan Huo,Yuesong Pan,Mengxing Wang,Zhongming Qiu,Lei Liu,Jeffrey L Saver,Zhongrong Miao,Cai XueLi

DOI: https://doi.org/10.1161/str.55.suppl_1.152

IF: 10.17

2024-02-01

Stroke

Abstract:Objective: Recent randomized trials demonstrated the benefit of endovascular thrombectomy for acute ischemic stroke with large infarct. We aimed to characterize the effect of time to treatment on the benefit of endovascular therapy compared to medical management among patients with acute large ischemic stroke. Methods: Analysis the Endovascular Therapy in Acute Anterior Circulation Large Vessel Occlusive Patients with a Large Infarct Core trial (ANGEL-ASPECT), which was a multicenter, randomized trial at 46 comprehensive stroke centers in China from August 2020 to October 2022. Onset to arterial puncture time (OPT) associated with outcomes of endovascular therapy were analyzed as a category and continuous variable. The primary outcome was favorable outcome (modified Rankin scale 0-3) at 90 days. Secondary outcomes included degree of disability (modified Rankin scale range), symptomatic intracranial hemorrhage, any intracranial hemorrhage, and mortality. Results: Among 455 eligible patients, the median age was 68 years, and median Alberta Stroke Program Early Computed Tomography Score was 3 (interquartile range 3-4). Compared with medical management alone, endovascular therapy plus medical management was associated with higher rates of favorable outcome with OPT within 6 hours (44.4% vs 29.9%, adjusted odds ratio[aOR] 2.78 [95% confidence interval [CI] 1.22-6.32]), 6-12 hours (45.7% vs 29.6%, aOR 2.39 [95% CI 1.21-4.71]), but not in OPT beyond 12 hours (51.6% vs 41.4%, aOR 2.05 [95% CI, 0.88-4.77]). The benefit in favorable outcome became nonsignificant after OPT of 13 hours and 22 minutes. In three OPT intervals, the odds of better disability outcome with endovascular therapy plus medical management than medical management alone were observed; the rates of symptomatic intracranial hemorrhage and mortality were similar, though the rates of any intracranial hemorrhage increased. Conclusion: In patients with large cerebral infarction, endovascular therapy plus medical management was efficacious in improving functional outcomes with acceptable safety in a broad time window of 0 to 24 hours, but greater benefit was observed with earlier treatment. A pooled analysis with larger sample size is needed.

peripheral vascular disease,clinical neurology
Surgery for urologic complications following radiotherapy for gynecologic cancer.

S. Krause,T. Hald,K. Steven

DOI: https://doi.org/10.3109/00365598709180304

Scandinavian Journal of Urology and Nephrology

Abstract:Urologic surgery was necessitated by complications following radiotherapy for gynecologic cancer in 17 patients. Four had recurrent malignant disease and 13 were without evidence of malignancy. The median interval to onset of the urologic complications was 18 (range 0-144) months. Ileal substitution was performed because of bilateral ureteral obstruction in two cases, and transureteroureterostomy for unilateral obstruction in one case. Vesicovaginal fistula was present in 14 patients, who underwent urinary diversion--cutaneous ureterostomy and ligation of the other ureter (6 cases), cutaneous ureterostomy and transureteroureterostomy (3) and ileal conduit diversion (5). The immediate morbidity and mortality were determined by the patients' general state of health rather than by presence or absence of recurrent malignant disease. The choice of diversion procedure should be guided by the patient's fitness, the status regarding recurrence of malignancy and the distribution of function between the two kidneys.
Endovascular treatment for acute ischemic stroke beyond the 24-h time window: Selection by target mismatch profile

Trung Quoc Nguyen,Mai Hoang Tran,Hai Ngoc Phung,Khang Vinh Nguyen,Hang T Minh Tran,Silke Walter,Dinh C Bao Hoang,Binh Nguyen Pham,Anh Le Tuan Truong,Vu Thanh Tran,Thanh N Nguyen,An Le Pham,Huy-Thang Nguyen

DOI: https://doi.org/10.1177/17474930231208817

2023-11-05

International Journal of Stroke

Abstract:International Journal of Stroke, Ahead of Print. Introduction:Endovascular treatment for acute ischemic stroke patients with large vessel occlusion (LVO) has been established as a promising clinical intervention within a late time window of 6–24 h after symptom onset. Patients with slow progression, however, may still benefit from endovascular treatment beyond the 24-h time window (very late window).Aim:The aim of this study is to report insight into the potential clinical benefits of endovascular treatment for acute ischemic stroke beyond 24 h from symptom onset.Methods:A retrospective analysis was performed on consecutive patients undergoing endovascular treatment for acute anterior circulation LVO ischemic stroke beyond 24 h. Participants were recruited between July 2019 and November 2020. Patients were selected based on the DAWN/DEFUSE 3 criteria (Perfusion-RAPID, iSchemaView) and patients receiving treatment beyond 24 h were compared to a group of patients receiving endovascular treatment between 6 and 24 h after symptom onset. The primary outcome was the proportion of patients with functional independence at 90 days (modified Rankin Scale score of 0–2). The secondary outcomes were shift modified Rankin Scale (mRS) analysis and successful reperfusion was defined by thrombolysis in cerebral infarction (TICI) 2b-3 on the final procedure. Safety outcomes were symptomatic intracranial hemorrhage and death at the 90-day follow-up. Propensity score (PS)-matched analyses were employed to rectify the imbalanced baseline characteristics between the two groups.Results:A total of 166 patients were recruited with a median age of 63.0 (56.0–69.0) and 28.9% of all patients were females. Patients in the beyond 24-h group had a longer onset-to-groin time (median = 27.2 vs 14.3 h, p 0.999). In PS-matched analyses, there were no significant differences among patients between the two groups in functional independence (50.0% vs 54.8%, p = 0.74), mortality (16.7% vs 9.68%, p = 0.50), or symptomatic hemorrhage (0% vs 6.45%, p = 0.53).Conclusion:Endovascular treatment can be performed safely and effectively in LVO patients beyond 24 h from symptom onset when selected by target mismatch profile. The clinical outcome of these patients was comparable to those treated in the 6- to 24-h window. Larger studies are needed to confirm these findings.

peripheral vascular disease,clinical neurology
Endovascular treatment or general treatment: how should acute ischemic stroke patients choose to benefit from them the most? A systematic review and meta-analysis

Weinan Yang,Lincheng Zhang,Qigu Yao,Weiyan Chen,Weiji Yang,Suqing Zhang,Lan He,Hong Li,Yuyan Zhang

DOI: https://doi.org/10.1097/MD.0000000000020187

IF: 1.6

2020-01-01

Medicine

Abstract:Background: Acute ischemic stroke due to large-vessel occlusion is a leading cause of death and disability, and therapeutic time window was limited to 4.5 hour when treated with intravenous thrombolysis. It has been acknowledged that endovascular treatment (EVT) is superior to general treatment (only medication, including intravenous recombinant tissue plasminogen activator (rt-PA)) in improving the outcome of AIS since 2015. However, the benefits were limited to improvement of functional outcomes and functional independence. Hence, this meta-analysis was conducted to summarize the benefits of EVT for acute ischemic stroke, explore underlying indications of EVT for AIS patients and suggest implications for clinical practice and future research. Methods: A search was performed to identify eligible studies in PubMed, Scopus and Web of Science updated to February 5, 2019. Functional outcomes, the modified Rankin Scale (mRS) 0-1, mRS 0-2, all-cause mortality, symptomatic intracerebral hemorrhage and asymptomatic intracerebral hemorrhage (aICH) at 90 days were selected as outcomes. Data was pooled to calculate the odds ratio (OR) and 95% confidence interval (CI). Heterogeneity, subgroup analysis, sensitivity analysis and publication bias were also performed in this meta-analysis. Results: Eighteen studies comprising 3831 patients were included and analyzed in this meta-analysis. In comparison with general treatment, improved functional outcomes (mRS 0-1: OR = 1.68, 95% CI = 1.43-1.97, inconsistency index [I-2] = 57%,P < .00001; mRS 0-2: OR = 1.78, 95% CI = 1.55-2.03,I-2 = 69%,P < .00001), reduced risk of all-cause mortality (OR = 0.82, 95% CI = 0.70-0.98,I-2 = 27%,P = .03) but higher risk of aICH (OR = 1.43, 95% CI = 1.05-1.95,I-2 = 0%,P = .02) at 90 days were found in AIS patients treated with EVT. Age < 70, National Institutes of Health Stroke Scale >= 20 and maximum delay for invention>5 hours could improve clinical outcomes following EVT. In sensitivity analysis, it showed that 2 studies had a great influence on the pooled ORs. No potential publication bias was found in this meta-analysis. Conclusion: Taken together, EVT, which led to improved functional outcomes and decreased risk of death, is superior to general treatment for AIS patients with age < 70, National Institutes of Health Stroke Scale >= 20 and maximum delay for invention>5 hours. Moreover, it suggests that "with mechanical thrombectomy" is potential favorable factor for improving aICH in comparison with general treatment.
Outcomes of Bridging Intravenous Thrombolysis Versus Endovascular Therapy Alone in Late-Window Acute Ischemic Stroke

Jelle Demeestere,Muhammad M Qureshi,Lieselotte Vandewalle,Anke Wouters,Daniel Strbian,Raul G Nogueira,Simon Nagel,Hiroshi Yamagami,Volker Puetz,Mohamad Abdalkader,Diogo C Haussen,Mahmoud H Mohammaden,Markus A Möhlenbruch,Marta Olivé-Gadea,Simon Winzer,Marc Ribo,Patrik Michel,João Pedro Marto,Kanta Tanaka,Shinichi Yoshimura,Nicolas Martinez-Majander,Francois Caparros,Hilde Henon,Liisa Tomppo,Anne Dusart,Flavio Bellante,João Nuno Ramos,Jessica Jesser,Sunil A Sheth,Santiago Ortega-Gutiérrez,James E Siegler,Stefania Nannoni,Johannes Kaesmacher,Tomas Dobrocky,Sergio Salazar-Marioni,Mudassir Farooqui,Pekka Virtanen,Rita Ventura,Syed F Zaidi,Alicia C Castonguay,Kazutaka Uchida,Ajit S Puri,Nobuyuki Sakai,Kazunori Toyoda,Behzad Farzin,Hesham E Masoud,Piers Klein,Jenny Bui,Federica Rizzo,Daniel P O Kaiser,Philippe Desfontaines,Davide Strambo,Charlotte Cordonnier,Eugene Lin,Peter A Ringleb,Daniel Roy,Osama O Zaidat,Urs Fischer,Jean Raymond,Robin Lemmens,Thanh N Nguyen,Muhammad M. Qureshi,Raul G. Nogueira,Diogo C. Haussen,Mahmoud H. Mohammaden,Markus A. Möhlenbruch,Sunil A. Sheth,James E. Siegler,Syed F. Zaidi,Alicia C. Castonguay,Ajit S. Puri,Hesham E. Masoud,Daniel P.O. Kaiser,Peter A. Ringleb,Osama O. Zaidat,Thanh N. Nguyen

DOI: https://doi.org/10.1161/strokeaha.124.046495

IF: 10.17

2024-05-16

Stroke

Abstract:Stroke, Ahead of Print. BACKGROUND:Studies comparing bridging intravenous thrombolysis (IVT) with direct endovascular therapy (EVT) in patients with acute ischemic stroke who present late are limited. We aimed to compare the clinical outcomes and safety of bridging IVT in patients with acute ischemic stroke due to anterior circulation large vessel occlusion who underwent EVT 6 to 24 hours after time last known well.METHODS:We enrolled patients with anterior circulation large vessel occlusion stroke and a National Institutes of Health Stroke Scale score of ≥6 from 20 centers across 10 countries in the multicenter retrospective CLEAR study (CT for Late Endovascular Reperfusion) between January 2014 and May 2022. We used inverse probability of treatment weighting modeling adjusted for clinical and imaging confounders to compare functional outcomes, reperfusion success, symptomatic intracranial hemorrhage, and mortality between EVT patients with and without prior IVT.RESULTS:Of 5098 patients screened for eligibility, we included 2749 patients, of whom 549 received bridging IVT before EVT. The timing of IVT was not recorded. Witnessed stroke onset and transfer rates were higher in the bridging IVT group (25% versus 12% and 77% versus 55%, respectively,Pvalue for both <0.0001), and time intervals between stroke onset and treatment were shorter (time last known well—start of EVT median 560 minutes [interquartile range, 432–791] versus 724 minutes [interquartile range, 544–912];P 6 hours after last known well.CONCLUSIONS:In patients with an anterior circulation large vessel occlusion stroke who underwent EVT 6 to 24 hours from last known well, bridging IVT was not associated with a difference in outcomes compared with direct EVT.REGISTRATION:URL:https://www.clinicaltrials.gov; Unique identifier: NCT04096248.

peripheral vascular disease,clinical neurology
Not Too Late to Intervene? A Meta-analysis of 13 Studies Evaluating the Association of Endovascular Therapy with Clinical Outcomes in Stroke Patients Presenting Beyond 24 Hours

Mohamed F Foheim,Abdulrahman Ibrahim Hagrass

DOI: https://doi.org/10.1101/2024.09.03.24313005

2024-09-04

Abstract:Background Association of endovascular therapy (EVT) with clinical outcomes beyond 24 hours remains unclear. We conducted a meta analysis to answer this question. Methods We searched for eligible studies in PubMed from inception until June 2023. The outcomes included functional independence, as assessed with 90-day modified Rankin Scale (mRS) scores (0 to 2), thrombolysis in cerebral infarction (TICI) scores (2b, c or 3), symptomatic intracranial hemorrhage (sICH), and 90 day mortality. Risk ratio (RR) and 95% confidence interval (CI) were pooled. Results We finally included 13 studies in our meta analysis (number of patients treated with EVT beyond 24 h=866). For single arm analysis, the pooled estimates of functional independence (mRS 0-2), sICH, and mortality were 0.342 (95% CI = 0.275, 0.410, P < 0.001), 0.062 (95% CI = 0.045 - 0.078, P < 0.001), and 0.232 (95% CI = 0.164, 0.301, P < 0.001); respectively with successful reperfusion (TICI 2b, c or 3) of 0.837 (95% CI = 0.812, 0.861, P < 0.001). Comparing EVT with medical management, the pooled analysis showed that EVT had a statistically significant advantage over medical management (RR = 2.62, 95% CI [1.38, 4.96], P = 0.003). However, our analysis showed a higher incidence of sICH in EVT group (RR = 3.58, 95% CI [1.53, 8.37], P = 0.003). When we pooled studies comparing EVT beyond 24 h with EVT within 6 to 24 h, the findings showed no statistically significant difference for functional independence, sICH, and 90d Mortality. Conclusion EVT is associated with better clinical outcomes than medical management beyond 24 hours. These results are iconoclastic enhancing a new paradigm in which a contemporary restriction to specific time window to treat patients rather than their own clinical and imaging characteristics seems to be anecdotal. Prospective studies are needed to confirm the best eligible patients for EVT in this newly proposed window extension.
Low-heat alkaline pretreatment of biomass for dairy anaerobic codigestion

G. Jin,T. Bierma

DOI: https://doi.org/10.1080/03601234.2014.929912

2014-07-28

Abstract:In this research, low-heat alkaline pretreatment was evaluated to determine the extent to which urban landscape waste (yard waste), corn stover, and switchgrass could be codigested under conditions typical of US farm-based anaerobic digestion (AD). Waste heat from combined heat and power (CHP) units associated with AD could make such pretreatment economical. Short-term batch digestion studies and 8-week continuous-feed studies were used to screen and evaluate various pretreatment conditions. Results indicate that maple and oak leaves did not digest well, even with pretreatment. Pretreatment did improve digestion of corn leaves and stalks as well as switchgrass. However, these materials also digested reasonably well even without pretreatment. No digester operational problems were observed during continuous-feed studies of intermittently stirred bench top digesters, but optimal levels of alkali, temperature, and pretreatment time may be specific to the feedstock, particle size, and digester loading rate. Results suggest that some common lignocellulosic biomass materials, such as corn stover and switchgrass, could be successfully codigested in many existing farm-based digesters. Interestingly, without pretreatment, switchgrass digestion improved over 20-fold when digested with seed culture from a dairy digester compared to seed culture from a municipal digester, suggesting that culture acclimation could be as important as pretreatment in improving digestion of specific lignocellulosic feedstocks.
Endovascular treatment over 24 hours after ischemic stroke onset: a single-center retrospective study

Shimin Liu,Wenfeng Cao,Lingfeng Wu,An Wen,Yongliang Zhou,Zhengbing Xiang,Wei Rao,Dongyuan Yao

DOI: https://doi.org/10.1007/s00234-022-03105-6

Neuroradiology

Abstract:Purpose: The aim of this study is to evaluate the safety and effectiveness of endovascular treatment (EVT) for acute ischemic stroke caused by large-vessel obstruction or stenosis (AIS-LVO/S) over 24 h after first AIS symptom recognition (FAISSR). Methods: A total of 33 AIS-LVO/S cases with EVT over 24 h after FAISSR during the period from January 2019 to February 2022 in our hospital were divided into the 90d mRS ≤ 2 group [favorable outcome (FO) group] and 90d mRS > 2 group [unfavorable outcome (UFO) group] and retrospectively analyzed. Results: The reperfusion was successfully established with EVT in 97% (32/33) of cases, and most (63.6%, 21/33) had 90d mRS ≤ 2 and only 36.4% (12/33) had 90d mRS > 2. Preoperative DWI-ASPECT and ASITN/SIR scores were significantly higher and NIHSS scores were significantly lower in the FO group than those in the UFO group (P < 0.05). In addition, the FAISSR to exacerbation time, FAISSR to groin puncture time, and FAISSR to reperfusion time were significantly longer, and the groin puncture to reperfusion time was significantly shorter in the FO group than those in the UFO group (P < 0.05), but there was no significant difference in the stroke exacerbation to groin puncture time (P > 0.05). The patients with cerebral infarction due to artery dissection had more favorable EVT outcomes, but the patients with posterior cerebral circulation infarction had very poor EVT outcomes. Conclusions: The FAISSR to groin puncture time over 24 h may not be a taboo for EVT and it may be safe and effective for AIS-LVO/S in anterior cerebral circulation, especially with lower preoperative NIHSS scores.

Midtrimester bacterial vaginosis and cervical length in women at risk for preterm birth.

Endovascular treatment for acute basilar artery occlusion due to different stroke etiologies of large artery atherosclerosis and cardioembolism.

Endovascular Treatment for Minor Acute Ischemic Strokes with Large Vessel Occlusion

Endovascular Treatment or General Treatment: How Should Acute Ischemic Stroke Patients Choose to Benefit from Them the Most?

Endovascular therapy versus medical management for ischemic stroke presenting beyond 24 hours: Systematic review and meta-analysis

Safety and efficacy of endovascular treatment for acute ischemic stroke of large-vessel occlusion beyond the time window based on imaging evaluation

Endovascular therapy beyond 24 hours for anterior circulation large vessel occlusion or stenosis in acute ischemic stroke: a retrospective study

Safety and clinical outcomes of endovascular therapy versus medical management in late presentation of large ischemic stroke

Endovascular treatment versus standard medical treatment in patients with established large infarct: a cohort study

Association between time to treatment and clinical outcomes in endovascular thrombectomy beyond 6 hours without advanced imaging selection

Effect of the Time from Onset to Recanalization on the Outcomes after Endovascular Treatment in Patients with Acute Stroke Due to Posterior Circulation Large Vessel Occlusion

Clinical Outcomes of Endovascular Treatment within 24 Hours in Patients with Mild Ischemic Stroke and Perfusion Imaging Selection.

A comparison of endovascular therapy and medical management in patients with large vessel occlusion mild stroke treated between 2015 and 2023: a systematic review and meta-analysis

Abstract 152: Endovascular Therapy versus Medical Management for Acute Ischemic Stroke With Large Infarct: A Time-Benefit Relationship Analysis

Surgery for urologic complications following radiotherapy for gynecologic cancer.

Endovascular treatment for acute ischemic stroke beyond the 24-h time window: Selection by target mismatch profile

Endovascular treatment or general treatment: how should acute ischemic stroke patients choose to benefit from them the most? A systematic review and meta-analysis

Outcomes of Bridging Intravenous Thrombolysis Versus Endovascular Therapy Alone in Late-Window Acute Ischemic Stroke

Not Too Late to Intervene? A Meta-analysis of 13 Studies Evaluating the Association of Endovascular Therapy with Clinical Outcomes in Stroke Patients Presenting Beyond 24 Hours

Low-heat alkaline pretreatment of biomass for dairy anaerobic codigestion

Endovascular treatment over 24 hours after ischemic stroke onset: a single-center retrospective study